Incredible research is happening in #Delaware. Congrats to Prelude Therapeutics on securing $60M in Series B financing. Prelude, working out of the Delaware Innovation Space (@DE_Innovates), is developing drugs to target cancer.
https://www.businesswire.com/news/home/20190612005176/en/Prelude-Therapeutics-Secures-60-Million-Expands-Management
#ChooseDelaware #NetDE
<< Read less >>
<< Read More >>
https://www.businesswire.com/news/home/20190612005176/en/Prelude-Therapeutics-Secures-60-Million-Expands-Management
#ChooseDelaware #NetDE